Aducanumab, an antibody developed by the University of Zurich, has been shown to trigger a meaningful reduction of harmful beta-amyloid plaques in patients with early-stage Alzheimer’s... Read more
HIGHLIGHTS FROM THE REALM OF POSSIBILITIES
NEW IDEAS
- A tiny molecule which can enter a solid tumor may allow for more accessible and effective cancer immunotherapies
- Is open science facing headwinds?
- A new paradigm to achieve privacy-preserving imaging by building a fundamentally new type of imager designed by AI
- The first hydrogel-based cartilage substitute that is even stronger and more durable than the real thing
- Could artificial intelligence help cure epilepsy?
- The opportunity for an entirely new type of therapeutic approach to treat Alzheimer’s and other forms of dementia
- A new broadly neutralizing antibody neutralizes all known coronavirus variants
- Could we get lower nuclear energy costs by using artificial intelligence?
- Putting an end to hospital bed sores with tiny optical sensors
- Replacing 100% of conventional aggregates in concrete with rubber from old tires
Copyright 2022 Innovation Toronto